Haemodynamic effects of riociguat in CTEPH and PAH: a 10-year observational study
Background Long-term treatment with riociguat has been shown to enhance exercise capacity in patients with pulmonary arterial hypertension (PAH) and inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH). This study sought to evaluate the long-term haemodynamic effe...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2021-09-01
|
| Series: | ERJ Open Research |
| Online Access: | http://openres.ersjournals.com/content/7/3/00082-2021.full |